Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
ARTICLE

Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons

Vladislav M. Sandler and Jean-Gaël Barbara
Journal of Neuroscience 1 June 1999, 19 (11) 4325-4336; DOI: https://doi.org/10.1523/JNEUROSCI.19-11-04325.1999
Vladislav M. Sandler
1New York Medical College, Department of Physiology, Valhalla, New York 10595
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Gaël Barbara
1New York Medical College, Department of Physiology, Valhalla, New York 10595
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Calcium-induced calcium release (CICR) is a mechanism by which local elevations of intracellular calcium (Ca2+) are amplified by Ca2+ release from ryanodine-sensitive Ca2+ stores. CICR is known to be coupled to Ca2+ entry in skeletal muscle, cardiac muscle, and peripheral neurons, but no evidence suggests that such coupling occurs in central neurons during the firing of action potentials. Using fast Ca2+ imaging in CA1 neurons from hippocampal slices, we found evidence for CICR during action potential-evoked Ca2+ transients. A low concentration of caffeine enhanced Ca2+ transient amplitude, whereas a higher concentration reduced it. Simultaneous Ca2+ imaging and whole-cell recordings showed that membrane potential, action potential amplitude, and waveform were unchanged during caffeine application. The enhancement of Ca2+ transients by caffeine was not affected by the L-type channel blocker nifedipine, the phosphodiesterase inhibitor IBMX, the adenylyl cyclase activator forskolin, or the PKA antagonist H-89. However, thapsigargin or ryanodine, which both empty intracellular Ca2+stores, occluded this effect. In addition, thapsigargin, ryanodine, and cyclopiazonic acid reduced action potential-evoked Ca2+ transients in the absence of caffeine. These results suggest that Ca2+ release from ryanodine-sensitive stores contributes to Ca2+signals triggered by action potentials in CA1 neurons.

  • hippocampus
  • slices
  • fura-2
  • patch clamp
  • caffeine
  • thapsigargin

Calcium ion (Ca2+) is an important second messenger that participates in the triggering and regulation of many neuronal processes, including neurotransmitter release (Mulkey and Zucker, 1991;Borst and Sakmann, 1996), synaptic plasticity (Bear and Malenka, 1994;Malenka, 1994), and transcription control (Hardingham et al., 1997). In central neurons a fast change in [Ca2+]i (free intracellular Ca2+) can be triggered in the soma and dendrites by sodium action potentials (Jaffe et al., 1992; Spruston et al., 1995). Although it generally is agreed that action potentials cause [Ca2+]i elevations by opening voltage-gated Ca2+ channels (Christie et al., 1995), it remains unclear whether such influx is the only source of Ca2+.

Ca2+-induced Ca2+ release (CICR), a process of Ca2+ mobilization involving ryanodine receptor (RyR) channels, has been described as a major contributor of action potential-evoked Ca2+ signals in muscles (Nabauer et al., 1989; Cannell et al., 1995; Lopez-Lopez et al., 1995) and in peripheral sensory neurons (Usachev and Thayer, 1997). Depolarization-induced Ca2+ influx also has been suggested to cause CICR in cerebellar Purkinje cells (Llano et al., 1994), but no clear demonstration of CICR during action potentials has been documented in central neurons.

Several requirements for CICR occurring in neurons can be predicted. Theoretical calculations estimate that high concentrations of Ca2+ can be reached only at distances of tens of nanometers from the mouth of a Ca2+ channel within microseconds (Chow et al., 1994;Cannell and Soeller, 1997; Klingauf and Neher, 1997; Soeller and Cannell, 1997). Therefore, a close proximity of RyR channels to voltage-gated Ca2+ channels is probably important and required for their opening. In addition to RyRs, endoplasmic reticulum (ER) Ca2+-ATPases (SERCA), coexpressed with RyRs, are also necessary for CICR.

These structural requirements for CICR have been documented in CA1 hippocampal pyramidal neurons. These cells have the highest levels of expression of the brain-type RyR3 (Furuichi et al., 1994), which is expressed in the soma, dendrites, and axon. Similarly, the highest expression levels of the SERCA-2, found in the brain, cardiac, and slow-twitch muscle, occur in the hippocampus as well as in the cerebellum, cortex, and thalamus (Miller et al., 1991). In addition, it has been shown that RyRs in central neurons are located mostly in close vicinity to the plasmalemma (for review, see Berridge, 1998). Moreover, they are colocalized together with the SERCA in the smooth ER (Sah et al., 1993; Sah and Dulhunty, 1994). Equally important is that the ER of CA1 pyramidal neurons is filled with Ca2+ at rest (Garaschuk et al., 1997).

Here, we tested whether Ca2+ influx evoked by either a single or a few action potentials triggers CICR and whether this could influence significantly the overall magnitude of action potential-induced Ca2+ signals. Using fast optical imaging (Lasser-Ross et al., 1991) in fura-2 AM-loaded hippocampal slices of the rat (Grynkiewicz et al., 1985; Garaschuk et al., 1997) and whole-cell patch-clamp recordings, we provide evidence in favor of this hypothesis.

MATERIALS AND METHODS

Slice preparation. Transverse hippocampal slices (300 μm thick) were prepared from 10- to 17-d-old Sprague Dawley rats as previously described (Tsubokawa and Ross, 1997), except that cutting was performed between 0 and 1°C. The cutting solution was composed of (in mm): 120 choline-Cl, 3 KCl, 8 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose, pH 7.4, when bubbled with 95% O2/5% CO2, 300–315 mOsm/kg. After cutting, the slices were warmed to 30–32°C for 30 min and then maintained at room temperature in normal saline composed of (in mm): 124 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose, pH 7.4, when bubbled with 95% O2/5% CO2.

Fura-2 AM loading procedure. CA1 pyramidal neurons were loaded with acetoxymethyl ester of fura-2 (fura-2 AM, Molecular Probes, Eugene, OR) similar to the procedure described in Garaschuk et al. (1997). Briefly, hippocampal slices were incubated for 13–15 min in a plastic tube containing 1 ml of fura-2 AM (15 μm) filled with 95% O2/5% CO2, at 35–36°C. Stock solutions of fura-2 AM (3.3 mm) were prepared in dimethyl sulfoxide. After loading, the slices were transferred to the recording chamber where they were washed for at least 30 min. The loading of neurons was restricted to the cytoplasm because the fluorescence measured at 600 nm disappeared within 2–3 min on the application of 30 μg/ml saponin (Golovina and Blaustein, 1997).

Recording of Ca2+ transients.[Ca2+]i measurements were made on pyramidal neurons from the CA1 region loaded either with fura-2 AM or bis-fura-2 through a patch pipette. High-speed digital fluorescence image sequences (25–30 msec frame intervals) were recorded with a cooled CCD camera (Lasser-Ross et al., 1991) on an upright Olympus BX50WI microscope equipped with a 40× water immersion objective, numerical aperture 0.8. Fura-2 fluorescence (F) was measured by using an excitation of 382 ± 6 nm and an emission >455 nm. Changes in [Ca2+]i are presented as the spatial averages of ΔF/F (in %) over cell bodies or dendrites, in which F is the fluorescence intensity at resting [Ca2+]i and ΔF is the time-dependent change in fluorescence corrected for bleaching. Maximal ΔF/F pseudocolor images were computed when antidromic action potentials were evoked. Regions of high ΔF/F matched the position of loaded neurons. Boxes of 5 × 5 pixels were chosen for the calculation of ΔF/F. The center of each box was located on the basis of the ΔF/F pseudocolor images. The positions of maximal ΔF/F regions were controlled throughout the experiments. To determine which box size was optimal to measure signals from single cells, we calculated ΔF/F values in the box containing the cell and in all of the surrounding boxes. ΔF/F values in the 5 × 5 pixels box containing the cell were 3.17 ± 0.5 times larger than in surrounding 5 × 5 pixels boxes (n = 4 cells). This value was 2.6 and 2.5 for box sizes of 3 × 3 and 7 × 7, respectively. All recordings were performed at 30°C in the presence of APV (50–100 μm) and CNQX (5–20 μm) to prevent the activation of excitatory postsynaptic potentials. Data are given as mean ± SEM throughout.

Background fluorescence and background signals in fura-2 AM-loaded slices. Background fluorescence was sampled in regions devoid of loaded cells in the stratum radiatum. Autofluorescence of the tissue, recorded in slices not loaded with fura-2 AM, accounted for 60.7% of the background fluorescence measured in slices loaded with fura-2 AM. The other part of background fluorescence was attributable to residual fura-2 AM that could not be washed from the slice and from stained cellular elements that could not be resolved visually. Background fluorescence was typically 40–60% of the fluorescence in loaded neurons (average 58.5 ± 2.6%; n = 7 slices). Background fluorescence in the fura-2 AM-loaded slices was compared with the background fluorescence in the whole-cell experiments when a neuron was loaded with bis-fura-2 (100–200 μm). In the latter case the background fluorescence accounted for only 10.8 ± 3.4%. In these experiments the background fluorescence originated predominantly from the autofluorescence of the tissue, because at ∼380 nm excitation the fluorescence of the residual (spilled) dye in the presence of 2 mm[Ca2+]o may be considered negligible (Grynkiewicz et al., 1985). Because the purpose of the experiments was to compare the [Ca2+]i changes in response to the application of different pharmacological agents rather than to calculate absolute calcium concentrations, no correction was made for background fluorescence. Fluorescence changes therefore are underestimated. When antidromic action potentials were evoked, ΔF/F signals were measured both in loaded cells and in surrounding regions in which background fluorescence was detected. These background signals contributed to 18.5 ± 2.8% (n = 5 slices) of signals in CA1 neurons. They probably originated from loaded fibers or fine dendrites. Background signals recorded far from the loaded cells were insensitive to treatments with caffeine, ryanodine, thapsigargin, or cyclopiazonic acid (CPA).

Stability of fluorescence and ΔF/F signals in fura-2 AM-loaded neurons. Fluorescence values (F), with no stimulation, were recorded throughout the experiments. Assuming that the concentration of the indicator remained constant during the experiments, F was taken as a measure of the resting [Ca2+]i. We noticed a small decrease in F with time occurring over all areas of slices, probably because of bleaching. However, because this decrease in Fwas linear, changes of resting [Ca2+]icould be detected as abrupt changes in F during drug applications. In our experiments only 20 μm CPA affected resting [Ca2+]i in some cells. Moreover, bleaching did not affect measurements of ΔF/F values significantly. ΔF/F, recorded every 5 min in loaded cells stimulated antidromically, were stable over 1 hr. A control histogram was built for the ratios between the amplitudes of two control Ca2+ signals evoked by five action potentials at a 5 min interval. The histogram was fit with a gaussian (see Fig.3E). The average ratio between amplitudes of two control Ca2+ signals was 99.9 ± 1.0% (n = 66 cells). For each slice two to four controls of ΔF/F were recorded at the beginning of each experiment.

Electrical stimulations. Ca2+ transients were evoked by using a 1 MΩ monopolar tungsten electrode, which was placed on the alveus for triggering antidromic action potentials. Stimulation pulses 100–500 μA, 200 μsec, 1–10 at 20 Hz, were delivered from an isolated stimulator (World Precision Instruments, Sarasota, FL). Action potentials recorded in some experiments with whole-cell patch clamp and associated Ca2+transients were all-or-none and showed a marked threshold below 500 μA. Stimulus intensity was set to obtain reproducible responses from 1–10 neurons in the field of view.

Electrical recordings. Combined measurements of membrane potential and [Ca2+]i were performed on individual neurons. Whole-cell tight seals were made onto cell bodies using video-enhanced DIC optics (Stuart and Sakmann, 1994). Bis-fura-2 was allowed to diffuse into cells for at least 15 min before Ca2+ recording. Patch pipettes were pulled from 1.5 mm outer diameter thick-walled glass tubing (number 1511-M, Friderick and Dimmock, Millville, NJ). Intracellular solution contained (in mm): 130 K-gluconate, 10 Na-gluconate, 4 NaCl, 2 Mg-ATP, 0.3 Na-GTP, and 10 HEPES, 0.06–0.2 bis-fura-2, pH-adjusted to 7.2 with KOH; osmotic pressure was 300 mOsm/kg. Open resistance of the pipettes was 5–7 MΩ in normal saline. After breaking into the cell, the holding current was always <50 pA and usually zero. No correction was made for the junction potential between the bath and the pipette.

Chemicals and drugs. Fura-2 AM and bis-fura-2 were obtained from Molecular Probes. Thapsigargin and CPA were purchased from Calbiochem (La Jolla, CA). CNQX and APV were from Research Biochemicals (Natick, MA). Other chemicals were obtained from Sigma (St. Louis, MO).

Perfusion system. All drugs were bath-applied through the perfusion system of the recording chamber. Solutions were exchanged at a rate of 1 ml/min, using a peristaltic pump (Rainin Instruments, Woburn, MA). The recording chamber had a volume of 2.4 ml. When a drug entered the chamber, its concentration rose approximately linearly by 10% of its maximal concentration every 9 sec, as assayed by measuring the fluorescence of a 0.4 μm fluorescein solution. Therefore, a solution exchange of 98% could be achieved within 1.5 min. This allowed a slow rise in drug concentration, which was particularly important for drugs applied to empty internal Ca2+ stores without inducing resting [Ca2+]i changes. A complete wash of fluorescein fluorescence required 10–15 min.

RESULTS

Changes in [Ca2+]i (intracellular Ca2+ concentration) were recorded in CA1 pyramidal neurons from hippocampal slices after antidromic stimulations in the alveus. When the stimulus intensity was increased, Ca2+ transients occurred in an all-or-none manner in individual somata (Figs. 1,2) and were blocked entirely by 1 μm TTX (Fig. 2C). With a single stimulus (1 pulse, 100–500 μA, 200 μsec) the occurrence of Ca2+ signals was correlated with the generation of action potentials in neurons recorded with whole-cell patch clamp (see Fig. 4A). This indicates that Ca2+transients were triggered by antidromically evoked action potentials. Ca2+ transient amplitudes (% ΔF/F), recorded in cells loaded with fura-2 AM, were, on average, 1.85 ± 0.14% for a single action potential, with decay time constants of 273.2 ± 32.1 msec (n = 17 cells). These fast kinetics suggest that the fura-2 concentration inside neurons was below 50 μm(Helmchen et al., 1996). Thus, dye buffering was probably low in our Ca2+ recordings.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Recording of all-or-none Ca2+transients in a CA1 neuron triggered by a single antidromic stimulation. A, Changes of [Ca2+]i during a single stimulation of increasing intensity in the alveus. Top panels, ΔF/F pseudocolor images during the stimulation show a clear area of high ΔF/F corresponding to a single CA1 neuron. Bottom traces correspond to spatial averages of ΔF/F over a 5 × 5 pixels area positioned over the stimulated neuron. B, Plot of maximal spatial averages of ΔF/Fagainst the stimulus intensity. C, Bright-field image of the stimulated neuron. D, Fluorescence image of the same neuron recorded at 380 nm. Scale bars: C,D, 20 μm.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Properties of Ca2+ transients recorded simultaneously in several pyramidal neurons from the CA1 layer of an hippocampal slice. A, ΔF/F pseudocolor images during five antidromic stimulating pulses. Note that at least six neurons are stimulated. B, Corresponding fluorescence image (380 nm) showing that high ΔF/F regions inA correspond to the fura-2-loaded neurons in the CA1 pyramidal cell layer. The alveus is upward in the micrograph. C, Ca2+ transients corresponding to the neurons shown in B. Thelight blue trace, sampled from region 5, was taken to illustrate a background signal and showed no visible loaded neuron. Inset, Example of a Ca2+ transient abolished with 1 μmTTX. D, Dependence of Ca2+ transients evoked by five action potentials on external [Ca2+]o (n = 5–20 cells for each concentration). Inset, Log plot of the same data.

Action potential-evoked Ca2+ signals were dependent on [Ca2+]o (external Ca2+). When [Ca2+]owas reduced from 2 to 1 mm or 100 μm, amplitudes of Ca2+ transients were 88.2 ± 2.5% (n = 9 cells) and 36.3 ± 3.0% (n = 14 cells) of control signals, respectively (Fig.2D).

Caffeine induces a transient increase in action potential-evoked Ca2+ signals

To examine whether CICR contributes to Ca2+signals evoked by action potentials, we used the xanthine derivative caffeine. Caffeine readily crosses plasma membranes, where it binds intracellularly to RyRs. If CICR were triggered during action potentials, caffeine either would increase Ca2+signals by sensitizing RyR channels (Sitsapesan and Williams, 1990) or would decrease them by a partial depletion of internal Ca2+ stores (Usachev et al., 1993; Shmigol et al., 1996).

In a first series of experiments a low concentration of caffeine (5 mm) was found to induce a small and reversible potentiation of Ca2+ signals evoked by action potentials (Fig.3). When caffeine was bath-applied for 5 min, Ca2+ signal amplitudes were increased by 15.4 ± 4.9, 22.5 ± 4.8, and 16.2 ± 4.9% within 1–3 min for 1, 5, and 10 action potentials, respectively (Fig.3A–C). Neurons that did not show the potentiation with caffeine were included in the statistics. The potentiation reached up to 78% and was observed in >89.3% of cells (see histogram, Fig.3E) (ANOVA, p < 0.001; n = 103 cells). Ca2+ transients returned to control values after 10 min of wash. The effect of caffeine was associated with no change in either basal F recorded in somata or a change in background fluorescence (Fig. 3D).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Effect of caffeine on Ca2+transients evoked by 1–10 antidromic stimulations. A, Ca2+ transients evoked by a single action potential were potentiated by the application of caffeine (5 min, 5 mm). Average data are illustrated on theright. B, Same as in A, except that five action potentials were evoked. C, Same as in A, except that 10 action potentials were evoked. Average data are from 10–16 cells. D, Time course of the action of caffeine (5 mm). Traces were recorded at 5 min intervals, except for the fourth trace, which was recorded after 1 min of caffeine application. Basal Fvalues, with no stimulation, are plotted correspondingly to each trace. (○), Basal F at the location of the cell; ■, background F (see Materials and Methods); (●), difference between the two fluorescence values. E, Histograms of the changes of Ca2+ transient amplitudes by 5 and 20 mm caffeine. The linein the histogram of caffeine action represents a fit of the control histogram (see Materials and Methods).

In contrast, a higher concentration of caffeine (20 mm) caused a reduction of Ca2+ signals of 8.9 ± 6.1% (n = 21 cells) (Fig. 3E), which partially recovered. Control Ca2+ signals were recorded in a saline in which sucrose (20 mm) was used instead of caffeine to mimic the change in osmolarity. This result is consistent with an expected reduction of Ca2+signals by caffeine depleting the ryanodine-sensitive internal Ca2+ stores. It suggests a contribution of CICR to action potential-evoked Ca2+ transients in CA1 neurons.

Caffeine-induced potentiation of Ca2+ transients is not attributable to changes in action potentials properties

Simultaneous whole-cell recordings and Ca2+imaging were performed to determine whether caffeine changed the action potential properties in pyramidal neurons. CA1 pyramidal neurons were filled with bis-fura-2 (200 μm) through a patch pipette. Single antidromic stimulations (200 μsec, <500 μA) evoked action potentials and associated Ca2+ transients of 2.0 ± 0.3% in somata and 3.5 ± 0.7% in the proximal apical dendrites (n = 5 cells) (Fig.4A,B). Caffeine application led to a potentiation of these Ca2+ signals both in somata and in the dendrites (Fig. 4A,B). Small changes in action potential amplitude and width did occur, but they were not significant (t test, p = 0.79 and p = 0.39, respectively; n = 5 cells) (Fig. 4C) and were not dependent on the application of caffeine. These changes did not affect Ca2+ signals significantly. Although the effect of caffeine was 16.4 ± 5.7% in somata and 13.8 ± 1.6% in the dendrites, action potential amplitudes were 101.5 ± 6.4 mV and 99.1 ± 6.3 mV before and during caffeine application, respectively (n = 5 cells) (Fig.4C). Furthermore, the effect of caffeine was not associated with a change in basal F in these experiments (data not shown). We conclude that caffeine potentiates Ca2+transients without modification of the amplitude or shape of the action potentials.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

The caffeine-induced increase in Ca2+ transients does not depend on a change in action potentials, which are recorded with whole-cell patch clamp.A, Caffeine (5 mm) potentiates Ca2+ transients both in the soma and in the proximal dendrites of a CA1 neuron recorded in current-clamp mode (top panels). Action potentials before, during, and after caffeine application are superimposed in the bottom panel. No significant change in action potential waveform is observed during the caffeine application. B, Time course of caffeine effect in a neuron recorded in whole-cell configuration. Three controls are shown separated by 5 min intervals. The fourth traceswere recorded after 1 min of caffeine application. C, Average data are from five neurons. Maximal ΔF/F values were recorded 10 and 5 min before caffeine application (Control 1 andControl 2, respectively), during the caffeine application, and after wash of caffeine. Maximal ΔF/F values were increased in the presence of caffeine (top plot). Basal fluorescence (F) recorded at 380 nm slightly and linearly increased in the soma but did not change when caffeine was applied or removed. Spike amplitude and spike width were unaffected by the application of caffeine (bottom plot).

The effect of caffeine is not mediated by protein phosphorylation

Caffeine is a known antagonist of phosphodiesterases (PDEs) (Butcher and Sutherland, 1962) and can trigger protein phosphorylation by increasing cAMP and/or cGMP levels (Beavo and Reifsnyder, 1990). Thus, a caffeine-induced potentiation of Ca2+signals could be attributable to an increased Ca2+influx mediated by a phosphorylation of voltage-dependent Ca2+ channels, as recently reported in CA1 neurons (Kavalali et al., 1997).

To exclude this possibility, we used 1-methyl-3-isobutylxanthine (IBMX), a nonspecific PDE inhibitor related to caffeine, but two orders of magnitude more potent (Wells et al., 1975). When IBMX (100 μm) was bath-applied for 5 min, a transient potentiation of Ca2+ signals was observed (12.2 ± 5.6%;n = 19 cells; ANOVA, p = 0.01) (Fig.5A, Table1). In the presence of IBMX, Ca2+ signals returned to control values within 15 min (86.7 ± 4.6%; n = 19 cells) (Fig.5A, Table 1). Caffeine was bath-applied consecutively in the presence of IBMX. This protocol did not prevent the potentiation of Ca2+ signals by caffeine, which was 10.5 ± 2.5% for five action potentials (ANOVA, p < 0.001; n = 19 cells) (Fig. 5A, Table1).

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

The caffeine-induced increase in Ca2+ transients is not mediated by a rise in cyclic nucleotides. A, IBMX (100 μm) has little effect on Ca2+ transients (second andthird traces) and does not occlude caffeine action (fourth and fifth traces).B, Same as in A except that forskolin (5 μm) was applied. C, Same as inA except that H-89 was used. Dashed linesindicate the time of application of IBMX, forskolin, or H-89.Solid lines indicate the 5 min caffeine application. Ca2+ transients in the presence of caffeine were recorded after 1 and 3 min of caffeine application. Except during the caffeine application, the traces are separated by 5 min intervals. Background F is plotted correspondingly to each Ca2+ transient in the bottom panels. The traces for A–C were recorded from three representative cells. See Table 1 for average results.

View this table:
  • View inline
  • View popup
Table 1.

Pharmacology of the effect of caffeine on action potential-evoked Ca2+ transients

Using forskolin, an activator of adenylyl cyclase (Seamon et al., 1985), we examined the contribution of cAMP to the potentiation of Ca2+ signals. When forskolin (5 μm) was bath-applied for 10 min, no increase in Ca2+signals was detected after 5–10 min of incubation (0.7 ± 3.1%; n = 16 cells) (Fig. 5B, Table 1). This finding strongly supports that an increase in cAMP cannot account for a potentiation of action potential-evoked Ca2+signals recorded in our conditions. Furthermore, after a 10 min preincubation with forskolin (5 μm), caffeine applied in the presence of forskolin caused a potentiation to 21.8 ± 7.1% (ANOVA, p < 0.001; n = 16 cells) (Fig.5B, Table 1). This result demonstrates that caffeine can potentiate Ca2+ signals independently of a cAMP production.

Finally, the possible involvement of the cAMP–PKA and cGMP–PKG pathways was assessed further with H-89, an antagonist of PKA and PKG at 1 μm (Chijiwa et al., 1990). H-89 alone had no effect on Ca2+ signals during a 10 min incubation (1.1 ± 1.8%; n = 14 cells) (Fig. 5C, Table 1). However, caffeine applied in the presence of H-89 caused a potentiation of Ca2+ signals of 19.5 ± 2.4% (ANOVA,p < 0.001; n = 14 cells) (Fig.5C, Table 1). We conclude that caffeine potentiates action potential-evoked Ca2+ signals independently of protein phosphorylation mediated by either cAMP or cGMP.

L-type channels are not needed for caffeine-induced potentiation of Ca2+ signals

The previous experiments suggest that the effect of caffeine cannot be accounted for by a modulation of voltage-gated Ca2+ channels, because the most likely upregulation of Ca2+ influx by caffeine would involve PKA. Furthermore, caffeine acting on adenosine receptors would rather inhibit Ca2+ influx (Zhu and Ikeda, 1993). However, another pathway independent of kinases and involving L-type channels could be implicated. It recently has been proposed that caffeine modifies a direct interaction between RyRs and L-type channels, leading to an increase of this open probability of RyRs (Chavis et al., 1996). We investigated this possibility in an experiment in which caffeine was applied while L-type channels were blocked by nifedipine (Tombaugh and Somjen, 1997).

Nifedipine (20 μm) maximally and partially inhibited action potential-evoked Ca2+ signals (Fig.6B). A 10 min preincubation with nifedipine did not prevent the caffeine-induced potentiation of Ca2+ transients (14.0 ± 2.3%;n = 16 cells; ANOVA, p < 0.001) (Fig.6A, Table 1). This result demonstrates that the caffeine-induced enhancement of action potential-evoked Ca2+ signals does not require L-type Ca2+ channels. Thus, an interaction between the RyRs and L-type channels is probably not responsible for the effect of caffeine in CA1 pyramidal neurons.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

L-type Ca2+ channels are not required for the effect of caffeine on Ca2+transients. A, Nifedipine (20 μm) reduces Ca2+ transient amplitude (fourth and fifth traces) but does not occlude caffeine action (sixth and seventh traces). Three controls are shown separated by 5 min intervals. The sixth and seventh traces were recorded after 1 and 3 min of caffeine application, respectively. No change in basal fluorescence (F) was observed when the drugs were applied. B, Dose–response curve of nifedipine on the reduction of Ca2+ transient amplitude. Each point is from five to six cells.

Ryanodine decreases action potential-evoked Ca2+transients and occludes the effect of caffeine

The findings presented thus far suggest that caffeine potentiated action potential-evoked Ca2+ transients independently of a modulation of Ca2+ influx by PKA or activation of RyR. A possible explanation of the action of caffeine is that caffeine favors CICR by interacting with the RyR channels, thereby enhancing their open probability (Rousseau and Meissner, 1989;Sitsapesan and Williams, 1990). If this were true, ryanodine, binding to the RyRs and locking them in a low-conductance open state (Coronado et al., 1994), should prevent the action of caffeine (Sitsapesan and Williams, 1990). To test this hypothesis, we used ryanodine, which was shown to have no effect on voltage-gated Ca2+currents and resting potential in CA1 pyramidal neurons (Belousov et al., 1995; Garaschuk et al., 1997).

Ryanodine (20 μm) irreversibly reduced Ca2+ transients evoked by one or five action potentials by 22.2 ± 4.0% (n = 24 cells) and 27.1 ± 2.9% (n = 24 cells), respectively (Fig.7A,B). This effect was observed within 10–15 min of ryanodine incubation. Ca2+ signal amplitude then reached a steady state (Fig. 7A,B). A similar effect of ryanodine was observed in neurons loaded with bis-fura-2 (200 μm) by using whole-cell patch clamp (28.0 ± 4.3,n = 5) (Fig. 7D), with no change in action potential amplitude (paired t test, p = 0.60; n = 5) (Fig. 7E). The percentage of reduction was greater when the cells were stimulated by five action potentials every 20 sec between measurements of Ca2+signals (Fig.8A,B). Such stimulation did not interfere with the stability of control Ca2+ transients, because their amplitudes were stable for >20 min under these conditions. The application of ryanodine with this protocol caused a reduction of Ca2+ transient amplitudes by 46.0 ± 1.5% of control (n = 30 cells) (Fig.8A,B, Table 1). This larger reduction of Ca2+ transients in stimulated neurons is consistent with the use-dependent block of caffeine-evoked Ca2+ transients by ryanodine reported by Garaschuk et al. (1997) and the Ca2+ dependence of ryanodine binding to RyRs (Coronado et al., 1994). The reduction of Ca2+ transients by ryanodine is unlikely to be attributed to Ca2+-dependent inactivation of Ca2+ influx, because no change in basal fluorescence was associated with application of ryanodine (see Fig.7A,B). The effect of ryanodine observed here is in agreement with a contribution of CICR to action potential-evoked Ca2+ transients.

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

Ryanodine reduces Ca2+transient amplitude. A, Ryanodine (20 μm) reduced Ca2+ transient amplitude to a stable level. Traces were recorded every 5 min. Ca2+ transients were evoked by five action potentials. No change in basal fluorescence (F) was associated with the application of ryanodine. B, Same as in A except that Ca2+ transients were evoked by a single action potential. C, Average data of the effect of ryanodine on Ca2+ transients evoked by five spikes (left bars) and one spike (right bars). Open bars, Controls; filled bars, ryanodine (20 μm). Data are from 20–24 cells. D, Ryanodine (20 μm) reduced Ca2+transient amplitude in a whole-cell recorded neuron. E, No change in action potential occurred when ryanodine was applied. Spikes and Ca2+ transients were recorded simultaneously. F, Average data of the effect of ryanodine (20 μm) in whole-cell recorded neurons on Ca2+ transient amplitude evoked by five spikes (left bars) and on the first spike amplitude (right bars). Open bars, Controls;filled bars, ryanodine (20 μm).

Fig. 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 8.

Ryanodine occludes the effect of caffeine.A, Ryanodine (20 μm) reduced the amplitude of Ca2+ transients evoked with five action potentials and occluded caffeine action on Ca2+transients. B, Selected traces (a–c) are shown corresponding to the points labeleda–c in the plot in A. The cell was stimulated by five action potentials every 20 sec between measurements of the Ca2+ transients. See Table 1 for average results.

Because ryanodine was able to reduce action potential-evoked Ca2+ transients, we tested ryanodine on the effect of caffeine. When cells were made to fire five action potentials at 20 Hz every 20 sec in the presence of ryanodine (20 μm) to deplete Ca2+ stores, caffeine failed to induce a potentiation of Ca2+ signals evoked by five action potentials but rather slightly decreased them (−5.4 ± 3.3%;n = 30 cells) (Fig.8A,B, Table 1). These experiments show that ryanodine can occlude the action of caffeine. We therefore conclude that caffeine probably favored CICR by interacting with the RyR channels, whereas ryanodine suppressed CICR induced by action potentials.

Effect of endoplasmic Ca2+-ATPase inhibitors on action potential-evoked Ca2+ transients

The involvement of internal Ca2+ stores in action potential-evoked Ca2+ transients was examined further by blocking endoplasmic Ca2+-ATPases. Thapsigargin, a sesquiterpene lactone, is an effective and irreversible inhibitor of endoplasmic ATPases (Thastrup, 1990; Thastrup et al., 1990) without a known influence on plasma membrane ATPases (Lytton et al., 1991). Thapsigargin (3 μm) was shown to empty efficiently the caffeine-sensitive internal Ca2+stores in CA1 pyramidal neurons (Garaschuk et al., 1997) with no effect on resting potential (Belousov et al., 1995).

Bath application of thapsigargin (500 or 3000 nm) irreversibly reduced Ca2+ signals evoked by one or five action potentials by 17.1 ± 3.4% (n = 16 cells) and 20.2 ± 3.0% (n = 32 cells) (Fig.9A,B), respectively. The decrease in signal amplitude reached a steady-state level of reduction in 30 min (data not shown). Furthermore, thapsigargin caused a change in Ca2+ signal kinetics, with decay phases being slower in the presence of thapsigargin (Fig. 9B, inset). A similar effect of thapsigargin (3 μm) was observed in neurons loaded with bis-fura-2 (60 μm) by using whole-cell patch clamp (19.2 ± 2.6, n = 5) (Fig.9C,D). In these experiments the action potential amplitudes were unaffected by the drug (paired t test,p = 0.7) (see Fig. 8D). No change in basal fluorescence was observed during thapsigargin application (data not shown), consistent with the reported lack of effect of thapsigargin on resting [Ca2+]i in neurons (Shmigol et al., 1995). Taken together, these results suggest that thapsigargin prevents CICR by depleting Ca2+ stores.

Fig. 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 9.

Thapsigargin reduces Ca2+transient amplitude and occludes the effect of caffeine.A, Thapsigargin (3 μm) reduced Ca2+ transient amplitude and occluded caffeine action on Ca2+ transients. B, Selected traces (a–c) are shown corresponding to thepoints labeled a–c in the plot inA. Inset, Traces a andb have been scaled to visualize the change in kinetics induced by thapsigargin. Time scale, 500 msec. C, Thapsigargin (3 μm) reduced Ca2+transient amplitude in a whole-cell recorded neuron. D, No change in action potential occurred when thapsigargin was applied. Ca2+ transients were evoked with five action potentials throughout.

We tested if thapsigargin could prevent the action of caffeine on action potential-evoked Ca2+ signals. Caffeine (5 mm) applied after 30 min of thapsigargin incubation failed to induce a potentiation of Ca2+ signals (see Fig.8A, Table 1). On average, caffeine reduced Ca2+ signals by 23.5 ± 5.8% (n = 5 cells) and 13.4 ± 3.0% (n= 32 cells) (Fig. 9A, Table 1) for one and five action potentials, respectively. This is consistent with the assumption that caffeine further depleted internal Ca2+ stores in the presence of thapsigargin. No potentiation by caffeine was ever observed in these experiments. These results further imply that the caffeine action required loaded internal Ca2+stores.

Because thapsigargin is an irreversible antagonist (Thastrup et al., 1990) and because it partially may inhibit Ca2+influx in some cells (Rossier et al., 1993; Nelson et al., 1994;Shmigol et al., 1995), we used CPA, a reversible and more specific blocker of SERCAs (Seidler et al., 1989). CPA (in the micromolar range) has been shown to have no effects on Ca2+ channels, resting potential, and action potential amplitude in neurons (Ishii et al., 1992; Nelson et al., 1994). These properties enabled us to study the effect of a reversible Ca2+ store depletion on action potential-evoked Ca2+ signals.

A 10 min application of CPA (30 nm) reduced Ca2+ transients by 19.6 ± 2.6% (n = 20 cells) (Fig.10C,D). Recovery by >96% of control signals occurred in ∼75% of cells with the washout of CPA. No change in basal fluorescence was detected when CPA was applied (Fig. 10C). These results indicate that Ca2+ transient amplitudes can be reduced when internal Ca2+ stores are emptied in a reversible manner. However, at such low concentration the effect of CPA was probably partial, because the reduction of Ca2+transient amplitudes and the effect on Ca2+ signal kinetics were smaller than those observed with thapsigargin. For this reason CPA was used at higher concentrations between 1 and 20 μm. CPA (>300 nm) had a similar effect on Ca2+ signal kinetics with that observed in the presence of thapsigargin. Furthermore, a reversible reduction of Ca2+ signals by 33.3 ± 5.2% was observed in 31.3% of cells (n = 10 cells) (Fig. 10). This result shows that the effect of CPA is reversible and dose-dependent. We conclude that the amplitude of action potential-evoked Ca2+ transients can be reduced in a reversible manner when internal Ca2+ stores are emptied slowly with no change in basal [Ca2+]i. These results further establish the contribution of CICR in setting the amplitude of action potential-evoked Ca2+ signals in CA1 pyramidal neurons.

Fig. 10.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 10.

Cyclopiazonic acid (CPA) reversibly reduces Ca2+ transient amplitude. A, CPA (3 μm) applied for 20 min reduced Ca2+transient amplitudes (third and fourth traces). A full wash of CPA allows for the complete recovery of Ca2+ transient amplitude. The traces were recorded every 10 min. B, Effect of CPA (3 μm) on the decay of Ca2+ transients. Transients have been scaled for a comparison of their kinetics. C, CPA (30 nm) applied for 10 min reduced Ca2+transient amplitudes (fourth and fifth traces). A full wash of CPA allowed for the complete recovery of Ca2+ transient amplitude (eighth trace). The traces were recorded every 5 min. No change in basal fluorescence (F) was associated with the application of CPA. D, Average results for the effect of >300 nm CPA (left bars) and 30 nm CPA (right bars). For each group of bars the first bar is the control, the second bar is CPA, and the third bar is wash.

DISCUSSION

Our results provide new evidence for a contribution of internal Ca2+ stores in elevations of [Ca2+]i associated with action potentials in CA1 pyramidal neurons. This conclusion is based on pharmacological manipulations of CICR, which either can increase or decrease action potential-evoked Ca2+ transients in these cells. Although this contribution does not seem predominant in magnitude, the contribution of internal Ca2+ stores to action potential-evoked Ca2+ transients may influence the subcellular patterns of [Ca2+]i increases profoundly. In addition, CICR may present new targets for neuromodulators controlling the amplitude of Ca2+ transients in the soma and dendrites of neurons.

A main argument in favor of a contribution of CICR to action potential-evoked change in [Ca]i was the caffeine sensitivity of Ca2+ transients. They were enhanced by a low concentration (5 mm) and reduced by a higher concentration (20 mm) of caffeine. Caffeine was shown to reduce action potential-evoked Ca2+ signals in Purkinje cells, but no enhancement with a low dose of caffeine was reported in this study (Kano, 1995). The sensitivity to caffeine found here has been reported in various neuronal cell types (Friel and Tsien, 1992; Usachev et al., 1993; Verkhratsky and Shmigol, 1996) and usually is attributed to the caffeine sensitivity of isolated RyRs (Sitsapesan and Williams, 1990). Low concentrations of caffeine increase the open probability of the RyR channels only when they are activated by Ca2+, thus favoring CICR once a suprathreshold [Ca2+]i is reached. Higher caffeine concentrations increase the sensitivity of RyRs to Ca2+ so that resting [Ca2+]i becomes sufficient to cause the depletion of Ca2+ stores. Our experiments support this view, because low concentrations of caffeine had no effect on resting [Ca2+]i but enhanced Ca2+ transients evoked by action potentials in a ryanodine-sensitive manner. A role of intact internal Ca2+ stores in the action of caffeine was established further because, on average, ryanodine and thapsigargin occluded the action of caffeine. However, a minor action of caffeine was observed in the presence of ryanodine or thapsigargin in 25 and 8% of cells, respectively. Therefore, it should be pointed out that a part of the action of caffeine might not be directly related to CICR. However, because the main effect of caffeine was not mediated by PKA and blocked by ryanodine and thapsigargin, we believe that caffeine revealed CICR in CA1 cells, as previously reported in other neurons (Kano et al., 1995; Usachev and Thayer, 1997). Also, however, CICR reported in peripheral sensory neurons is a large regenerative process that significantly contributes to Ca2+ transients (Usachev and Thayer, 1997), whereas the magnitude of CICR induced by caffeine in CA1 pyramidal cells seems rather modest.

Caffeine has been used in CA1 neurons to show that ryanodine-sensitive Ca2+ stores contain releasable Ca2+ at rest (Garaschuk et al., 1997). This stored Ca2+ is required for the caffeine-induced potentiation of Ca2+ transients because it was occluded by the depletion of these Ca2+ stores. However, because caffeine was slowly bath-applied in our study, it did not induce a significant rise in resting [Ca2+]i. A possible slow Ca2+ release caused by caffeine application probably was counteracted effectively by both extrusion and uptake mechanisms. For caffeine-evoked calcium release to be observed, a fast change in RyRs sensitivity to Ca2+ is required. Under these conditions Ca2+-dependent inactivation of the RyRs has no time to occur (Hernández-Cruz et al., 1997). This explains why rapidly puffer-applied caffeine releases large amounts of Ca2+ (Garaschuk et al., 1997; Hernández-Cruz et al., 1997), whereas slow caffeine applications are ineffective. Other Ca2+-releasing agents such as ryanodine, thapsigargine, or CPA were slowly bath-applied and did not affect resting [Ca2+] either.

Experiments with caffeine did not provide direct evidence that CICR could be triggered during action potentials. Our data obtained with ryanodine, thapsigargin, and CPA further suggested that internal Ca2+ stores participate not only in the clearance of Ca2+ from the cytoplasm, as shown elsewhere (Markram et al., 1995; Fierro et al., 1998), but also in setting the amplitude of Ca2+ transients. Ryanodine has been shown to reduce action potential-evoked Ca2+ transients in several peripheral neurons (Cohen et al., 1997; Usachev and Thayer, 1997; Moore et al., 1998), in agreement with an underlying CICR. Our results show that ryanodine reduces Ca2+ transients during a single action potential in CA1 neurons. Furthermore, the use-dependent block of Ca2+ signals by ryanodine, observed in the present study, fits well with the reported action of ryanodine on RyRs of other central neurons (Kano et al., 1995;Garaschuk et al., 1997). The block of ER-ATPases by thapsigargin or CPA also reduced Ca2+ transients and affected their time course. Although thapsigargin was shown to block Ca2+ voltage-dependent channels in some cells (Rossier et al., 1993; Nelson et al., 1994; Shmigol et al., 1995), a low concentration reduced depolarization-induced Ca2+ transients in dorsal root ganglion neurons with no effect on Ca2+ influx (Shmigol et al., 1995). In agreement, we observed that the effect of thapsigargin on the decay and amplitude of Ca2+ transients developed in a parallel manner, suggesting that the reduction in Ca2+transient amplitude was related to the depletion of Ca2+ stores. Furthermore, the dose-dependent and reversible inhibition observed with CPA, which was shown to block caffeine-induced release in CA1 neurons (Garaschuk et al., 1997), supports our conclusions that store depletion affects action potential-evoked Ca2+ transients. Finally, the effects of ryanodine, thapsigargin, and CPA cannot be explained by a Ca2+-dependent modulation of voltage-dependent Ca2+ currents because resting [Ca2+]i was unchanged in our experimental conditions. Such modulation was reported when resting [Ca2+]i rose above 100 nmby puffer-applying Ca2+-releasing agents (Kramer et al., 1991). Our measurements of basal [Ca2+]i are not consistent with such rises. We therefore conclude that a CICR component underlies action potential-evoked Ca2+ transients with the involvement of ryanodine-sensitive stores. A participation of other stores such as ryanodine-insensitive and InsP3-sensitive Ca2+ stores or a novel type of ryanodine-insensitive Ca2+ store (Jacobs and Meyer, 1997) is not excluded, nevertheless.

The small contribution of CICR to action potential-evoked Ca2+ transients described here raises the question of its role and relevance. The contribution of CICR to global somatic Ca2+ transients may be estimated to be between 10 and 30%, according to experiments with thapsigargin, ryanodine, and CPA. However, if CICR occurs in a localized manner, it could be predominant in some subcellular regions. Both experimental evidence and theoretical derivations suggest that CICR might occur in small Ca2+ microdomains (Bezprozvanny et al., 1991;Hernández-Cruz et al., 1997; Berridge, 1998; Neher, 1998). Measurements of Ca2+ signals that rise in 1 msec also favor the idea that CICR might be triggered locally (Ross et al., 1998). Localized CICR has been suggested to control neuronal excitability by producing slow afterhyperpolarizations in peripheral and central neurons (for review, see Berridge, 1998), including hippocampal CA1 neurons (Torres et al., 1996). Thus CICR, described in this study, is probably important in regulating the excitability of CA1 neurons. In addition, CICR could occur more widely within the cytoplasm and distal dendrites when internal Ca2+ stores are sensitized by cADPRibose or InsP3 in the presence of neurotransmitters. In such a case the role of CICR might be relevant to synaptic plasticity and the coupling of synaptic inputs to gene transcription in the nucleus.

Footnotes

  • This work was supported by a Human Frontier Science Program Fellowship to J.G.B. and by grants from the Human Frontier Science Program and the National Institute of Neurological Diseases and Stroke (NS16295) to W.N.R. We are indebted to Dr. W. N. Ross for helpful discussions and in whose laboratory the experiments were performed. We thank Dr. J. C. Poncer for comments on this manuscript and Dr. D. Johnson for discussions.

    Both authors equally contributed to this work.

    Correspondence should be addressed to Dr. Jean-Gaël Barbara, New York Medical College, Department of Physiology, Valhalla, NY 10595.

    Dr. Sandler’s present address: Howard Hughes Medical Institute, Department of Cardiology, Children’s Hospital, Harvard Medical School, Boston, MA 02115.

REFERENCES

  1. ↵
    1. Bear MF,
    2. Malenka RC
    (1994) Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 4:389–399.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Beavo JA,
    2. Reifsnyder DH
    (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150–155.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Belousov AB,
    2. Godfraind JM,
    3. Krnjevic K
    (1995) Internal Ca2+ stores involved in anoxic responses of rat hippocampal neurons. J Physiol (Lond) 486:547–556.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Berridge MJ
    (1998) Neuronal calcium signaling. Neuron 21:13–26.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Bezprozvanny I,
    2. Watras J,
    3. Ehrlich BE
    (1991) Bell-shaped calcium–response curves of Ins1,4,5P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351:751–754.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Borst JG,
    2. Sakmann B
    (1996) Calcium influx and transmitter release in a fast CNS synapse. Nature 383:431–434.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Butcher RW,
    2. Sutherland EW
    (1962) Adenosine 3′,5′-phosphate in biological materials. J Biol Chem 237:1244–1250.
    OpenUrlFREE Full Text
  8. ↵
    1. Cannell MB,
    2. Soeller C
    (1997) Numerical analysis of ryanodine receptor activation by L-type channel activity in the cardiac muscle diad. Biophys J 73:112–122.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Cannell MB,
    2. Cheng H,
    3. Lederer WJ
    (1995) The control of calcium release in heart muscle. Science 268:1045–1049.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Chavis P,
    2. Fagni L,
    3. Lansman JB,
    4. Bockaert J
    (1996) Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature 382:719–722.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Chijiwa T,
    2. Mishima A,
    3. Hagiwara M,
    4. Sano M,
    5. Hayashi K,
    6. Inoue T,
    7. Naito K,
    8. Toshioka T,
    9. Hidaka H
    (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267–5272.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Chow RH,
    2. Klingauf J,
    3. Neher E
    (1994) Time course of Ca2+ concentration triggering exocytosis in neuroendocrine cells. Proc Natl Acad Sci USA 91:12765–12769.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Christie BR,
    2. Eliot LS,
    3. Ito K,
    4. Miyakawa H,
    5. Johnston D
    (1995) Different Ca2+ channels in soma and dendrites of hippocampal pyramidal neurons mediate spike-induced Ca2+ influx. J Neurophysiol 73:2553–2557.
    OpenUrlPubMed
  14. ↵
    1. Cohen AS,
    2. Moore KA,
    3. Bangalore R,
    4. Jafri MS,
    5. Weinreich D,
    6. Kao JPY
    (1997) Ca2+ induced Ca2+ release mediates Ca2+ transients evoked by single action potentials in rabbit vagal afferent neurones. J Physiol (Lond) 499:315–328.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Coronado R,
    2. Morrissette J,
    3. Sukhareva M,
    4. Vaughan DM
    (1994) Structure and function of ryanodine receptors. Am J Physiol (Lond) 266:C1485–C1504.
    OpenUrlPubMed
  16. ↵
    1. Fierro L,
    2. DiPolo R,
    3. Llano I
    (1998) Intracellular calcium clearance in Purkinje cell somata from rat cerebellar slices. J Physiol (Lond) 510:499–512.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Friel DD,
    2. Tsien RW
    (1992) A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog sympathetic neurones modulates effects of Ca2+ entry on [Ca2+]i. J Physiol (Lond) 450:217–246.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Furuichi T,
    2. Furutama D,
    3. Hakamata Y,
    4. Nakai J,
    5. Takeshima H,
    6. Mikoshiba K
    (1994) Multiple types of ryanodine receptor/Ca2+ release channels are differentially expressed in rabbit brain. J Neurosci 14:4794–4805.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Garaschuk O,
    2. Yaari Y,
    3. Konnerth A
    (1997) Release and sequestration of calcium by ryanodine-sensitive stores in rat hippocampal neurones. J Physiol (Lond) 502:13–30.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Golovina VA,
    2. Blaustein MP
    (1997) Spatially and functionally distinct Ca2+ stores in sarcoplasmic and endoplasmic reticulum. Science 275:1643–1648.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Grynkiewicz G,
    2. Poenie M,
    3. Tsien RY
    (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Hardingham GE,
    2. Chawla S,
    3. Johnson CM,
    4. Bading H
    (1997) Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385:260–265.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Helmchen F,
    2. Imoto K,
    3. Sakmann B
    (1996) Ca2+ buffering and action potential-evoked Ca2+ signaling in dendrites of pyramidal neurons. Biophys J 70:1069–1081.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Hernández-Cruz A,
    2. Escobar AL,
    3. Jiménez N
    (1997) Ca2+-induced Ca2+ release phenomena in mammalian sympathetic neurons are critically dependent on the rate of rise of trigger Ca2+. J Gen Physiol 109:147–167.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Ishii Y,
    2. Kawai T,
    3. Watanabe M
    (1992) Inhibitory effects of cyclopiazonic acid on the spike after-hyperpolarization in rat sympathetic neurons. Jpn J Pharmacol 58:451–456.
    OpenUrlPubMed
  26. ↵
    1. Jacobs JM,
    2. Meyer T
    (1997) Control of action potential-induced Ca2+ signaling in the soma of hippocampal neurons by Ca2+ release from intracellular stores. J Neurosci 17:4129–4135.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Jaffe DB,
    2. Johnston D,
    3. Lasser-Ross N,
    4. Lisman JE,
    5. Miyakawa H,
    6. Ross WN
    (1992) The spread of Na+ spikes determines the pattern of dendritic Ca2+ entry into hippocampal neurons. Nature 357:244–246.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Kano M,
    2. Garaschuk O,
    3. Verkhratsky A,
    4. Konnerth A
    (1995) Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurones. J Physiol (Lond) 487:1–16.
    OpenUrlPubMed
  29. ↵
    1. Kavalali ET,
    2. Hwang KS,
    3. Plummer MR
    (1997) cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. J Neurosci 17:5334–5348.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Klingauf J,
    2. Neher E
    (1997) Modeling buffered Ca2+ diffusion near the membrane: implications for secretion in neuroendocrine cells. Biophys J 72:674–690.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Kramer RH,
    2. Kaczmarek LK,
    3. Levitan ES
    (1991) Neuropeptide inhibition of voltage-gated calcium channels mediated by mobilization of intracellular calcium. Neuron 6:557–563.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Lasser-Ross N,
    2. Miyakawa H,
    3. Lev-Ram V,
    4. Young SR,
    5. Ross WN
    (1991) High time resolution fluorescence imaging with a CCD camera. J Neurosci Methods 36:253–261.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Llano I,
    2. DiPolo R,
    3. Marty A
    (1994) Calcium-induced calcium release in cerebellar Purkinje cells. Neuron 12:663–673.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Lopez-Lopez JR,
    2. Shacklock PS,
    3. Balke CW,
    4. Wier WG
    (1995) Local calcium transients triggered by single L-type calcium channel currents in cardiac cells. Science 268:1042–1045.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Lytton J,
    2. Westlin M,
    3. Hanley MR
    (1991) Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266:17067–17071.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Malenka RC
    (1994) Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78:535–538.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Markram H,
    2. Helm PJ,
    3. Sakmann B
    (1995) Dendritic calcium transients evoked by single back-propagating action potentials in rat neocortical pyramidal neurons. J Physiol (Lond) 485:1–20.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Miller KK,
    2. Verma A,
    3. Snyder SH,
    4. Ross CA
    (1991) Localization of an endoplasmic reticulum calcium ATPase mRNA in rat brain by in situ hybridization. Neuroscience 43:1–9.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Moore KA,
    2. Cohen AS,
    3. Kao JPY,
    4. Weinreich D
    (1998) Ca2+-induced Ca2+ release mediates a slow post-spike hyperpolarization in rabbit vagal afferent neurons. J Neurophysiol 79:688–694.
    OpenUrlPubMed
  40. ↵
    1. Mulkey RM,
    2. Zucker RS
    (1991) Action potentials must admit calcium to evoke transmitter release. Nature 350:153–155.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Nabauer M,
    2. Callewaert G,
    3. Cleemann L,
    4. Morad M
    (1989) Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science 244:800–803.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Neher E
    (1998) Vesicle pools and Ca2+ microdomains: new tools for understanding their roles in neurotransmitter release. Neuron 20:389–399.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Nelson EJ,
    2. Bangalore R,
    3. Benson T,
    4. Kass RS,
    5. Hinkle PM
    (1994) Inhibition of L-type calcium channel activity by thapsigargin and 2,5-t-butylhydroquinone, but not by cyclopiazonic acid. Biochem J 302:147–154.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Ross WN,
    2. Gray R,
    3. Lasser-Ross N
    (1998) High speed [Ca2+]i imaging of neurons in brain slices. Imaging living cells: a laboratory manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
  45. ↵
    1. Rossier MF,
    2. Python CP,
    3. Burnay MM,
    4. Schlegel W,
    5. Vallotton MB,
    6. Capponi AM
    (1993) Thapsigargin inhibits voltage-activated calcium channels in adrenal glomerulosa cells. Biochem J 296:309–312.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Rousseau E,
    2. Meissner G
    (1989) Single cardiac sarcoplasmic reticulum Ca2+ release channel: activation by caffeine. Am J Physiol 256:H328–H333.
    OpenUrlPubMed
  47. ↵
    1. Sah P,
    2. Dulhunty A
    (1994) Subcellular distribution of ryanodine receptor-like and calcium ATPase-like immunoreactivity in brainstem and cerebellar neurones of rat and guinea pig. Neurosci Lett 166:143–148.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Sah P,
    2. Francis K,
    3. McLachlan EM,
    4. Junankar P
    (1993) Distribution of ryanodine receptor-like immunoreactivity in mammalian central nervous system is consistent with its role in calcium-induced calcium release. Neuroscience 54:157–165.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Seamon KB,
    2. Vaillancourt R,
    3. Daly JW
    (1985) Modulation of forskolin binding to rat brain membranes. J Cyclic Nucleotide Protein Phosphor Res 10:535–549.
    OpenUrlPubMed
  50. ↵
    1. Seidler NW,
    2. Jona I,
    3. Vegh M,
    4. Martonosi A
    (1989) Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum. J Biol Chem 265:17816–17823.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Shmigol A,
    2. Kostyuk P,
    3. Verkhratsky A
    (1995) Dual action of thapsigargin on calcium mobilization in sensory neurons: inhibition of Ca2+ uptake by caffeine-sensitive pools and blockade of plasmalemmal Ca2+ channels. Neuroscience 65:1109–1118.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Shmigol A,
    2. Svichar N,
    3. Kostyuk P,
    4. Verkhratsky A
    (1996) Gradual caffeine-induced Ca2+ release in mouse dorsal root ganglion neurons is controlled by cytoplasmic and luminal Ca2+. Neuroscience 73:1061–1067.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Sitsapesan R,
    2. Williams AJ
    (1990) Mechanisms of caffeine activation of single calcium-release channels of sheep cardiac sarcoplasmic reticulum. J Physiol (Lond) 423:425–439.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Soeller C,
    2. Cannell MB
    (1997) Numerical simulation of local calcium movements during L-type calcium channel gating in the cardiac diad. Biophys J 73:97–111.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Spruston N,
    2. Schiller Y,
    3. Stuart G,
    4. Sakmann B
    (1995) Activity-dependent action potential invasion and calcium influx into hippocampal CA1 dendrites. Science 268:297–300.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Stuart GJ,
    2. Sakmann B
    (1994) Active propagation of somatic action potentials into neocortical pyramidal cell dendrites. Nature 367:69–72.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Thastrup O
    (1990) Role of Ca2+-ATPases in regulation of cellular Ca2+ signaling, as studied with the selective microsomal Ca2+-ATPase inhibitor, thapsigargin. Agents Actions 29:8–15.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Thastrup O,
    2. Cullen PJ,
    3. Drobak BK,
    4. Hanley MR,
    5. Dawson AP
    (1990) Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 87:2466–2470.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    1. Tombaugh GC,
    2. Somjen GG
    (1997) Differential sensitivity to intracellular pH among high- and low-threshold Ca2+ currents in isolated rat CA1 neurons. J Neurophysiol 77:639–653.
    OpenUrlPubMed
  60. ↵
    1. Torres GE,
    2. Arfken CL,
    3. Andrade R
    (1996) 5-Hydroxytryptamine4 receptors reduce afterhyperpolarization in hippocampus by inhibiting calcium-induced calcium release. Mol Pharmacol 50:1316–1322.
    OpenUrlAbstract
  61. ↵
    1. Tsubokawa H,
    2. Ross WN
    (1997) Muscarinic modulation of spike backpropagation in the apical dendrites of hippocampal CA1 pyramidal neurons. J Neurosci 17:5782–5791.
    OpenUrlAbstract/FREE Full Text
  62. ↵
    1. Usachev YM,
    2. Thayer SA
    (1997) All-or-none Ca2+ release from intracellular stores triggered by Ca2+ influx through voltage-gated Ca2+ channels in rat sensory neurons. J Neurosci 17:7404–7414.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. Usachev YM,
    2. Shmigol A,
    3. Pronchuk N,
    4. Kostyuk P,
    5. Verkhratsky A
    (1993) Caffeine-induced calcium release from internal stores in cultured rat sensory neurons. Neuroscience 57:845–859.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Verkhratsky A,
    2. Shmigol A
    (1996) Calcium-induced calcium release in neurones. Cell Calcium 19:1–14.
    OpenUrlCrossRefPubMed
  65. ↵
    1. Wells JN,
    2. Wu YJ,
    3. Baird CE,
    4. Hardman JG
    (1975) Phosphodiesterases from porcine coronary arteries: inhibition of separated forms by xanthenes, papaverine, and cyclic nucleotides. Mol Pharmacol 11:775–783.
    OpenUrlAbstract/FREE Full Text
  66. ↵
    1. Zhu Y,
    2. Ikeda SR
    (1993) Adenosine modulates voltage-gated Ca2+ channels in adult rat sympathetic neurons. J Neurophysiol 70:610–620.
    OpenUrlPubMed
Back to top

In this issue

The Journal of Neuroscience: 19 (11)
Journal of Neuroscience
Vol. 19, Issue 11
1 Jun 1999
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons
Vladislav M. Sandler, Jean-Gaël Barbara
Journal of Neuroscience 1 June 1999, 19 (11) 4325-4336; DOI: 10.1523/JNEUROSCI.19-11-04325.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons
Vladislav M. Sandler, Jean-Gaël Barbara
Journal of Neuroscience 1 June 1999, 19 (11) 4325-4336; DOI: 10.1523/JNEUROSCI.19-11-04325.1999
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • hippocampus
  • slices
  • fura-2
  • patch clamp
  • caffeine
  • thapsigargin

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Calcium Influx via L- and N-Type Calcium Channels Activates a Transient Large-Conductance Ca2+-Activated K+Current in Mouse Neocortical Pyramidal Neurons
  • Neural Correlates of Competing Fear Behaviors Evoked by an Innately Aversive Stimulus
  • Distinct Developmental Modes and Lesion-Induced Reactions of Dendrites of Two Classes of Drosophila Sensory Neurons
Show more ARTICLE
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.